Target intelligence / Profile preview

Zinc finger protein 169 (ZNF169)

Target
ZNF169
Molecular classification
Transcription factor, Zinc finger protein, C2H2-type zinc finger protein
01

Overview

Zinc finger protein 169 (ZNF169) is a DNA-binding transcription factor belonging to the C2H2-type zinc finger protein family, and is encoded by the ZNF169 gene located on chromosome 9q22.3[1][4]. ZNF169 functions by binding RNA polymerase II transcription regulatory regions and directly interacts with the promoter of the ANKZF1 gene, upregulating its transcription[2][3]. Overexpression of ZNF169 promotes cell proliferation and suppresses apoptosis in colorectal cancer models, suggesting an oncogenic role—especially via the ZNF169/ANKZF1 axis[2][3]. The expression and function of ZNF169 in other tissues and cancers is still being investigated, but bioinformatic and cell-based studies implicate it in cancer progression and possibly other transcriptional regulatory pathways.

Other names
MGC51961
02

Mechanism of action

No drugs are specifically known to target ZNF169 directly. Theoretically, drugs that inhibit the ZNF169/ANKZF1 axis could act by suppressing ZNF169-mediated transcriptional activation, thereby reducing cell proliferation and improving apoptosis in cancer (inferred from disease mechanism studies)

03

Biological functions

Transcriptional regulation (predominantly as a DNA-binding transcription factor, RNA polymerase II-specific)Regulation of cell proliferationModulation of cell apoptosisPotential roles in cell signaling, DNA repair, and cell migration (as are common among zinc finger proteins)
04

Disease associations

Cancer (notably colorectal cancer and possibly skin cancer)Malignant essential hypertension (association reported)Multiple self-healing squamous epithelioma (association reported)
05

Safety considerations

Since ZNF169 plays a role in transcriptional regulation and cell proliferation, therapeutic targeting could carry a risk of off-target effects impacting normal gene expression, cellular homeostasis, and possibly causing cytotoxicity in proliferating normal cells (general concern for transcription factor targeting; not specific clinical evidence)
06

Biomarkers

Elevated expression of ZNF169 may act as a prognostic indicator in colorectal cancer

Beyond the preview

Go deeper on Zinc finger protein 169 (ZNF169).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 169 (ZNF169).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call